NasdaqGM - Delayed Quote USD
XOMA Royalty Corporation (XOMAO)
25.00
-0.15
(-0.60%)
At close: May 2 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
221,277
234,301
140,382
166,562
Total Liabilities Net Minority Interest
139,356
145,580
16,368
24,686
Total Equity Gross Minority Interest
81,921
88,721
124,014
141,876
Total Capitalization
188,796
207,239
124,014
141,876
Preferred Stock Equity
49
49
49
49
Common Stock Equity
81,872
88,672
123,965
141,827
Capital Lease Obligations
929
389
34
229
Net Tangible Assets
56,012
88,721
108,864
141,876
Working Capital
101,230
149,814
54,435
84,006
Invested Capital
200,141
212,733
123,965
141,827
Tangible Book Value
55,963
88,672
108,815
141,827
Total Debt
119,198
124,450
34
229
Net Debt
16,615
--
--
--
Share Issued
11,782.72
11,495.49
11,454.03
11,315.26
Ordinary Shares Number
11,782.72
11,495.49
11,454.03
11,315.26
Preferred Shares Number
2,584
2,584
2,584
2,584
12/31/2021 - 4/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QBIO Q BioMed Inc.
0.0001
0.00%
BYSI BeyondSpring Inc.
1.6900
-5.59%
VCEL Vericel Corporation
38.95
+2.72%
KOD Kodiak Sciences Inc.
4.8000
+6.90%
LCTX Lineage Cell Therapeutics, Inc.
0.4907
-2.64%
TARS Tarsus Pharmaceuticals, Inc.
47.36
-5.84%
GPCR Structure Therapeutics Inc.
27.09
-0.88%
REGN Regeneron Pharmaceuticals, Inc.
605.61
+2.65%
VKTX Viking Therapeutics, Inc.
29.36
+2.60%